Natural Health News – The new guidelines, taking a look based on the evidence in the complementary and alternative medicines (CAM) for multiple sclerosis (MS) have just been released in the US ..
the new guidelines , issued by the American Academy of Neurology (AAN ) they are based on a review of evidence from several CAM therapies.
Multiple sclerosis is a progressive neurological disease characterized by interrupted communication between the brain and the body, resulting in symptoms ranging from blurred vision to muscle weakness and pain.
Most people experience first symptoms of MS between the ages of 20 and 40. Currently there is no cure available and conventional treatments often have severe side effects. Therefore there is a profound unmet additional therapies that help patients manage distressing symptoms in daily need as well as for the treatment of progressive forms of the disease for which there are few treatment options.
The test began four therapies that might fit the bill: extracts of oral cannabis, tetrahydrocannabinol (THC), and a mouth spray cannabinoid, he said, it could be useful in relieving spasticity and the pain; Magnetic therapy and Gingko biloba can relieve fatigue; and reflexology could alleviate paresthesia.
A comprehensive review
The panel study comprehensively reviewed research in a long list of CAM therapies used in MS – everything from cannabinoids, the bee venom therapy, and low-fat diet with omega-3 supplements Ginkgo biloba , magnetic therapy, and reflexology. It’s research results were published in the journal neurology .
therapies were divided into individual categories: Cannabinoids, mind-body medicine (eg, biofeedback, hypnosis), based on biology (glucosamine, linoleic acid) practices, handling practices and based in the body (yoga, massage therapy), and energy medicine (naturopathic practices).
The search uncovered nine good quality studies to investigate cannabis therapies, suggesting different benefits for the use and benefits.
In patients with relapsing-remitting (RR), secondary progressive (SP), and primary progressive types (PP) multiple sclerosis, the panel concluded that extracts of oral cannabis was effective in reducing both symptoms of spasticity in the patient reported pain and not related to central neuropathic pain.
It was also found that THC could probably be effective in reducing the symptoms of spasticity and neuropathic pain not (level B) reported by patients. The benefit to the two can continue for 1 year.
In general, cannabinoids were well tolerated. mild or moderate adverse effects were reported by 50% to 80% of study participants in both treatment groups and placebo. central nervous system side effects such as dizziness, drowsiness and difficulty concentrating, were more common in people taking cannabinoids. Dizziness was the most common adverse effect such, affecting 15% to 50% of participants.
There is insufficient evidence, the researchers say, that smoking cannabis would produce the same benefits.
CAM use is high
The number of patients with MS using 1 or more CAM therapies is “huge, easily up to 80%,” Dr. investigators said main Vijayshree Yadav of the Oregon Health & Science University in Portland, although this study was not found they were all effective.
Among the other CAM therapies that were Ginkgo biloba was found to be possibly effective for 4 weeks in reducing fatigue in patients with RR, SP and PP forms of MS . However, it did not seem effective in improving cognitive function. The researchers noted that the quality of gingko products can be a factor in the effectiveness of this therapy.
Reviewers evaluated 4 studios reflexology, which involves applying manual pressure on specific points of the feet. They concluded that reflexology is likely to be effective in reducing paresthesia associated-MS over 11 weeks, but the data are insufficient to assess its use for pain, quality of life, disability, spasticity, fatigue , cognition, bowel or bladder function, depression, anxiety or insomnia in MS.
Magnetic therapy may be effective for fatigue, but not for depression, the panel concluded.
Given the controversial nature of the results – particularly with respect to cannabis – researchers presented their findings in a highly qualified manner. They found that oral cannabis extract spray and reviewed are not currently available in the US, and that the overall evidence of CAM is somewhat sparse.
Currently only THC – dronabinol (Marinol, Abbvie) -. It is approved only for nausea related to chemotherapy and vomiting in cancer patients, and to boost appetite in HIV-infected
Yadaz also claims of pain relief experienced by patients was “just subjective changes as reported by patients, “although it is worth asking why the perception of their own levels of pain and relief of patients being dismissed so lightly.
regime Cari Loder (the tricyclic antidepressant plus phenylalanine lofepramine and vitamin B12), bee venom, and low-fat diet with omega -3 supplements were not found to be effective.
As for the other CAM therapies panel investigated, there was no evidence that they were effective, or said Dr. Yadav. However, he stressed that at present many therapies researchers are wrong, or has not been investigated at all, which does not mean they are not effective; it just is not there evidence about its effectiveness.